Two Sigma Investments »

Alnylam Pharmaceuticals shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2011-12-31 $436k 54k 8.15

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Doordash Cl A (DASH)
Microsoft Corporation Call Option (MSFT)
Micron Technology (MU)
Apple (AAPL)
Carvana Cl A (CVNA)
Jd.com Spon Ads Cl A (JD)
Snowflake Cl A (SNOW)
Alphabet Cap Stk Cl A (GOOGL)
Cme (CME)
NVIDIA Corporation (NVDA)
Pfizer (PFE)
Thermo Fisher Scientific (TMO)
Fortinet (FTNT)

View all positions for Two Sigma Investments

Top funds holding Alnylam Pharmaceuticals

Capital World Investors
FMR
Vanguard Group
BlackRock
Capital Research Global Investors
Wellington Management Company
Baillie Gifford & Co
Capital Research and Management Company - Division 3
Dodge & Cox
State Street Corporation
T. Rowe Price Associates
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
American Century Companies

View all funds holding Alnylam Pharmaceuticals